Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02K Hold
100
﹤0.01% 969
2026
Q1
$3.61K Hold
100
﹤0.01% 999
2025
Q4
$4.71K Sell
100
-36
-26% -$1.52K ﹤0.01% 984
2025
Q3
$4.42K Buy
136
+36
+36% +$1.28K ﹤0.01% 958
2025
Q2
$4.12K Hold
100
﹤0.01% 889
2025
Q1
$4.17K Hold
100
﹤0.01% 916
2024
Q4
$5.86K Hold
100
﹤0.01% 888
2024
Q3
$6.91K Hold
100
﹤0.01% 871
2024
Q2
$6.38K Hold
100
﹤0.01% 875
2024
Q1
$9.39K Hold
100
﹤0.01% 824
2023
Q4
$7.35K Hold
100
﹤0.01% 837
2023
Q3
$6.23K Hold
100
﹤0.01% 863
2023
Q2
$7.39K Hold
100
﹤0.01% 828
2023
Q1
$7.88K Hold
100
﹤0.01% 817
2022
Q4
$6.83K Hold
100
﹤0.01% 781
2022
Q3
$5K Hold
100
﹤0.01% 850
2022
Q2
$6K Hold
100
﹤0.01% 867
2022
Q1
$6K Hold
100
﹤0.01% 882
2021
Q4
$8K Buy
+100
New +$8.02K ﹤0.01% 893

Other funds holding BRKR

HM Payson & Co's BRKR Position: Q2 2026 in Review

HM Payson & Co held its Bruker (BRKR) position steady in Q2 2026 at 100 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #969.

HM Payson & Co first reported a position in BRKR in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.39K in Q1 2024. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • HM Payson & Co held 100 shares of Bruker worth $6.02K as of Q2 2026.
  • HM Payson & Co left its Bruker share count unchanged in Q2 2026.
  • Bruker made up ﹤0.01% of HM Payson & Co's portfolio in Q2 2026, its #969 holding.
  • HM Payson & Co first reported a position in Bruker in Q4 2021 and has held it in 19 quarters since.
  • HM Payson & Co's Bruker position peaked at $9.39K in Q1 2024.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.